Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||A Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder|
- Screening Protocol [ Time Frame: Screening ] [ Designated as safety issue: No ]This is a prescreening for potential participation in research studies.
|Study Start Date:||March 2003|
|Estimated Study Completion Date:||December 2020|
|Estimated Primary Completion Date:||December 2020 (Final data collection date for primary outcome measure)|
The ADHD Clinical Research Program at Massachusetts General Hospital currently offers a range of protocols addressing different aspects of ADHD in children and adolescents. Although these protocols have received prior IRB approval, potential participants present with a widely varied set of complaints not always discernable in a telephone screening interview. This state of affairs often makes it difficult to ask subjects and their parents to sign a specific protocol's consent form without obtaining additional clinical information. Because of this, we are proposing that potential subjects and their parents undergo an in-depth clinical assessment that will allow them to be screened by a clinician for eligibility to a diverse clinical research program.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00592436
|Contact: Rebecca Grossman, BAemail@example.com|
|United States, Massachusetts|
|Massachusetts General Hospital||Recruiting|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Joseph Biederman, MD||Massachusetts General Hospital|